Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Details Narrative)

v3.21.2
Organization and Summary of Significant Accounting Policies (Details Narrative)
 1 Months Ended 3 Months Ended 6 Months Ended
Jul. 16, 2021
Jul. 08, 2021
Jul. 31, 2020
Jul. 22, 2020
Aug. 16, 2021
Jun. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Integer
$ / shares
shares
Jun. 30, 2020
USD ($)
Dec. 31, 2020
shares
Condensed Cash Flow Statements, Captions [Line Items]                    
Reverse Stock Split     As a result of the Reverse Stock Splits, every 10,000 shares of the Company’s common stock then outstanding was combined and automatically converted into one share of the Company’s common stock              
Common stock shares authorized | shares           10,000,000,000   10,000,000,000   10,000,000,000
Preferred stock shares authorized | shares           5,000,000   5,000,000    
Preferred Stock, Par or Stated Value Per Share | $ / shares           $ 0.01   $ 0.01    
Estimated contractual allowances           $ 4,000,000.0 $ 8,400,000 $ 9,500,000 $ 18,900,000  
Bad debts           1,300,000 2,700,000 4,300,000 4,000,000.0  
Allowance for adjustment of revenue           5,300,000 11,100,000 13,800,000 22,900,000  
Net revenues           928,849 2,069,019 278,157 3,910,109  
Deemed dividend           $ 99,300,000 $ 149,600,000 $ 0 $ 0  
Visual MED Clinical Solutions Corporation [Member] | Series B Preferred Stock [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Preferred Stock, Par or Stated Value Per Share | $ / shares           $ 1,000   $ 1,000    
Preferred Stock, Dividend Rate, Percentage               90.00%    
[custom:NumberOfTradingDays] | Integer               10    
Assets, Noncurrent           $ 8,500,000   $ 8,500,000    
Gain (Loss) on Disposition of Assets for Financial Service Operations               10,700,000    
[custom:GainsLossesOnSalesAssumptionAmount]               $ 2,200,000    
Visual MED Clinical Solutions Corporation [Member] | Series B Preferred Stock [Member] | Noncontrolling Interest [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Conversion of Stock, Shares Issued | shares               14,000    
Health Technology Solutions Inc And Advanced Molecular Services Group [Member] | Series B Preferred Stock [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Gain (Loss) on Disposition of Assets for Financial Service Operations               $ 8,500,000    
Subsequent Event [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Reverse Stock Split every 1,000 shares of the Company’s then outstanding common stock was combined and automatically converted into one share of the Company’s common stock       1-for 1,000 reverse stock split          
Board of Directors [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Reverse Stock Split       1-for-10,000 reverse stock split            
Board of Directors [Member] | Subsequent Event [Member]                    
Condensed Cash Flow Statements, Captions [Line Items]                    
Reverse Stock Split   1-for-1,000 reverse stock split